BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, July 12, 2026
Home
»
Topics
» Immuno-oncology, BioWorld Science
Immuno-oncology, BioWorld Science
RSS
Approval to initiate NOVOMAb-G2 phase I studies granted by the FDA
May 31, 1996
Encouraging results of IDEC-C2B8 trial reported
May 31, 1996
Multikine trial commenced
May 31, 1996
Single-chain immunotoxin targeted to the CD40 antigen effect as cytotoxic agent
May 31, 1996
Daiwa's MGN-3 demonstrates immunotherapeutic activity
May 31, 1996
Role of DF3 in human carcinoma and potential therapeutics
May 24, 1996
Medarex presents MDX-210 phase I/II interim results
May 24, 1996
ImClone, E. Merck continue cancer vaccine collaboration
May 24, 1996
Vical, Corixa to collaborate on immunotherapeutic drugs for cancer
May 24, 1996
Patent protection obtained for IDEC-C2B8
May 24, 1996
Previous
1
2
…
993
994
995
996
997
998
999
1000
1001
Next
RSS